The NYT piece captures African frustration with the African CDC's response but glosses over entrenched funding asymmetries that predate this outbreak. Observational analyses of the 2014-2016 epidemic (Lancet Infectious Diseases, n=28 countries, no RCTs feasible due to emergency ethics) documented response delays averaging 4-6 months longer in sub-Saharan settings versus high-income nations, with pharma investment skewed by conflicts of interest favoring profitable vaccines over endemic preparedness. Synthesizing this with a 2023 BMJ Global Health review (observational cohort across 15 outbreaks) reveals the same 'panic-neglect' cycle: $2.8B mobilized for West Africa only after export risks emerged, dwarfing routine allocations. Mainstream coverage misses how these patterns erode trust and delay detection, perpetuating a resource hierarchy where African agencies receive under 10% of global health security funds despite bearing disproportionate burdens.